Biomaterial Database

Antinuclear antibodies in patients taking L1. 1991

V Berdoukas

UI	MeSH Term	Description	Entries
D007592	Joint Diseases	Diseases involving the JOINTS.	Arthropathies,Arthropathy,Joint Disease
D011728	Pyridones	Pyridine derivatives with one or more keto groups on the ring.	Pyridinones
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077543	Deferiprone	A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.	1,2-Dimethyl-3-hydroxy-4-pyridinone,1,2-Dimethyl-3-hydroxypyrid-4-one,1,2-Dimethyl-3-hydroxypyridin-4-one,3-Hydroxy-1,2-dimethyl-4-pyridinone,DMOHPO,Ferriprox,HDMPP,1,2 Dimethyl 3 hydroxy 4 pyridinone,1,2 Dimethyl 3 hydroxypyrid 4 one,1,2 Dimethyl 3 hydroxypyridin 4 one,3 Hydroxy 1,2 dimethyl 4 pyridinone
D000974	Antibodies, Antinuclear	Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease.	Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

V Berdoukas

Antinuclear antibodies in rosacea patients.

February 2013, Postepy dermatologii i alergologii,

V Berdoukas

[Antinuclear antibodies in elderly patients].

November 1985, Wiadomosci lekarskie (Warsaw, Poland : 1960),

V Berdoukas

Antinuclear antibodies in psychiatric patients.

April 1994, Acta psychiatrica Scandinavica,

V Berdoukas

Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies.

June 2020, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,

V Berdoukas

Antinuclear antibodies in patients on acebutolol.

May 1980, British journal of clinical pharmacology,

V Berdoukas

Antinuclear antibodies in patients with malignancies.

August 1972, Lancet (London, England),

V Berdoukas

Anti-IgG antibodies and antinuclear antibodies in allergic patients.

November 1981, Allergy,

V Berdoukas

Antinuclear antibodies in patients with lichen planus.

February 1997, Experimental dermatology,